Search clinical trials for: Dasatinib Maximum Tolerated Dose
Total 84 results
-
Memorial Sloan Kettering Cancer CenterBoehringer Ingelheim; National Comprehensive Cancer NetworkCompletedHead and Neck Cancer | Squamous Cell CancerUnited States
-
GlaxoSmithKlineCompleted
-
AB ScienceTerminatedMultiple MyelomaUnited States, France
-
RemeGen Co., Ltd.RecruitingGastric Cancer | HER2 Overexpressing Gastric CarcinomaChina
-
Rambam Health Care CampusUnknown
-
M.D. Anderson Cancer CenterCompleted
-
Hospices Civils de LyonUnknownSystemic Wegener's GranulomatosisFrance
-
ElsanRecruiting
-
European Organisation for Research and Treatment...Active, not recruitingCarcinoma, Squamous Cell of Head and NeckFrance, Spain, Belgium, Italy, United Kingdom
-
PfizerRecruitingNon-Small Cell Lung CancerNorway
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States
-
Case Comprehensive Cancer CenterCompletedAcute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Myeloproliferative Neoplasm | Acute Biphenotypic Leukemia | Hodgkins DiseaseUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
Universidad Autonoma de Nuevo LeonCompletedPlantar Fascitis | Botulinum Toxins, Type AMexico
-
King's College Hospital NHS TrustKing's College London; Fight for Sight (Funder)RecruitingEye Diseases | Macular Degeneration, Wet | Sub-Macular HemorrhageUnited Kingdom
-
Canadian Cancer Trials GroupBristol-Myers Squibb; Pfizer; Hoffmann-La Roche; AstraZeneca; Seagen Inc.RecruitingLymphoma, Non-Hodgkin | Multiple Myeloma | Advanced Solid TumorsCanada
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
Centro Nacional de Investigaciones Oncologicas...Apices Soluciones S.L.; Hospital Universitario de Fuenlabrada; Grupo Hospital...CompletedMetastatic Disease | Adenocarcinoma of Rectum | Adenocarcinoma of ColonSpain
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedBrain and Central Nervous System Tumors | Long-term Effects Secondary to Cancer Therapy in Children | Drug/Agent Toxicity by Tissue/Organ | Bone Marrow SuppressionUnited States
-
Fondazione per la Medicina PersonalizzataActive, not recruitingBreast Cancer | Non Small Cell Lung Cancer | Gastrointestinal Cancer | Other CancerItaly
-
OHSU Knight Cancer InstituteAbbVie; Oregon Health and Science UniversityRecruitingB Acute Lymphoblastic Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Mixed Phenotype Acute LeukemiaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Lymphoblastic LymphomaUnited States
-
The Netherlands Cancer InstituteBristol-Myers Squibb; Eli Lilly and Company; Bayer; GlaxoSmithKline; Merck Sharp... and other collaboratorsRecruitingCancer | Neoplasm | Tumors | NeoplasiaNetherlands
-
National Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States
-
Martin HuelsmannRecruitingHeart Diseases | Diabetes Mellitus, Type 2New Zealand, Austria, Netherlands, Spain, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Ph-Like Acute Lymphoblastic Leukemia | Refractory Ph-Like Acute Lymphoblastic LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Puerto Rico, Israel
-
National Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Adult T Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Adult L1 Acute Lymphoblastic Leukemia | Adult L2 Acute Lymphoblastic...United States
-
National Cancer Institute (NCI)Not yet recruiting
-
National Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Acute Lymphoblastic Leukemia, BCR-ABL1-LikeUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
National Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Canada, Australia, New Zealand, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | t(9;22) | BCR-ABL1 Fusion Protein ExpressionUnited States